In our study, we used the data from The Cancer Genome Atlas (TCGA) to explore the expression of ARHGEF39 and the correlation between ARHGEF39 expression and the prognosis of ccRCC. Here, ARHGEF39 is linked to nonpapillary renal cell carcinoma.